Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01052155|
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : March 14, 2011
|Condition or disease||Intervention/treatment|
|Chronic Pain||Other: Urine Drug Testing|
Recruitment is indicated in patients with chronic pain management with or without controlled substance therapy.
This is a diagnostic accuracy study performed in an interventional pain management referral center in the United States.
|Study Type :||Observational|
|Estimated Enrollment :||1000 participants|
|Official Title:||Accuracy of Point of Care (POC) or In-office Urine Drug Testing (Immunoassay) in Chronic Pain Patients: A Prospective Analysis of Immunoassay and Liquid Chromatography Tandem Mass Spectometry (LC/MS/MS)|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||June 2010|
- Other: Urine Drug Testing
LC/MS/MS Laboratory EvaluationOther Name: In-office Urine Drug Testing (Immunoassay)
- Diagnostic accuracy [ Time Frame: 72 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01052155
|Principal Investigator:||Laxmaiah Manchikanti, MD||Ambulatory Surgery Center, Paducah|